U. Schlokat et al., PRODUCTION OF HIGHLY HOMOGENEOUS AND STRUCTURALLY INTACT RECOMBINANT VON-WILLEBRAND-FACTOR MULTIMERS BY FURIN-MEDIATED PROPEPTIDE REMOVAL IN-VITRO, Biotechnology and applied biochemistry, 24, 1996, pp. 257-267
Recombinant human von Willebrand Factor (rvWF), a multimeric glycoprot
ein essential to haemostasis, has been developed as a potential therap
eutic agent for treatment of von Willebrand disease (vWD), Permanent C
hinese-hamster ovary (CHO)-rvWF cell clones co-expressing recombinant
furin (rfurin) were established in order to ensure complete wWF propep
tide removal [Fischer, Schlokat, Mitterer, Reiter, Mundt, Turecek, Sch
warz and Dorner(1995) FEES Lett, 375, 259-262], Large quantities of ma
terial are required for in vivo tests and clinical studies. This deman
d is commonly met by achieving high-yield expression of the desired pr
otein via amplification, Go-amplification of rfurin, necessary to comp
letely process increasing amounts of wWF precursor, could not be accom
plished, presumably due to lethal effects of overexpressed rfurin for
the host cells [Creemers (1994) Ph,D. Thesis, University of Leuven], R
ecent reports have inferred that rfurin can only mediate wWF processin
g intracellularly [Rehemtulla and Kaufman (1992) Blood 79, 2349-2355;
Rehemtulla, Dorner and Kaufman (1992) Proc, Natl, Acad, Sci, U.S.A. 89
, 8235-8239], We report here that rvWF-precursor processing, however,
occurs predominantly extracellularly upon rfurin co-expression, Mixing
experiments employing rfurin- as well as rvWF-precursor-containing co
nditioned media demonstrate that wWF precursors are accessible and cle
avable by rfurin in vitro, Exposure to rfurin in vitro converts the he
terogeneous multimer pattern typical of incompletely processed wWF mul
timers into highly homogeneous and structurally intact multimers super
ior to the ones exhibited by plasma-derived vWF, These findings thus d
emonstrate the feasibility of large-scale production of a completely p
rocessed, intact and homogeneous rvWF preparation, based on individual
rvWF-precursor high-yield expression and subsequent propeptide remova
l by rfurin in vitro.